These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 17898003)

  • 1. Hypocretin (orexin) loss and sleep disturbances in Parkinson's Disease.
    Fronczek R; Overeem S; Lee SY; Hegeman IM; van Pelt J; van Duinen SG; Lammers GJ; Swaab DF
    Brain; 2008 Jan; 131(Pt 1):e88. PubMed ID: 17898003
    [No Abstract]   [Full Text] [Related]  

  • 2. Parkinson's disease, sleepiness and hypocretin/orexin.
    Baumann CR; Scammell TE; Bassetti CL
    Brain; 2008 Mar; 131(Pt 3):e91. PubMed ID: 17898005
    [No Abstract]   [Full Text] [Related]  

  • 3. Progressive dopamine and hypocretin deficiencies in Parkinson's disease: is there an impact on sleep and wakefulness?
    Wienecke M; Werth E; Poryazova R; Baumann-Vogel H; Bassetti CL; Weller M; Waldvogel D; Storch A; Baumann CR
    J Sleep Res; 2012 Dec; 21(6):710-7. PubMed ID: 22747735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypocretin (orexin) loss in Parkinson's disease.
    Fronczek R; Overeem S; Lee SY; Hegeman IM; van Pelt J; van Duinen SG; Lammers GJ; Swaab DF
    Brain; 2007 Jun; 130(Pt 6):1577-85. PubMed ID: 17470494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parkinson's disease comorbid with narcolepsy presenting low CSF hypocretin/orexin level.
    Maeda T; Nagata K; Kondo H; Kanbayashi T
    Sleep Med; 2006 Dec; 7(8):662. PubMed ID: 17097921
    [No Abstract]   [Full Text] [Related]  

  • 6. Hypocretin-1 (orexin A) deficiency in acute traumatic brain injury.
    Baumann CR; Stocker R; Imhof HG; Trentz O; Hersberger M; Mignot E; Bassetti CL
    Neurology; 2005 Jul; 65(1):147-9. PubMed ID: 16009905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid-orexin levels and sleep attacks in four patients with Parkinson's disease.
    Asai H; Hirano M; Furiya Y; Udaka F; Morikawa M; Kanbayashi T; Shimizu T; Ueno S
    Clin Neurol Neurosurg; 2009 May; 111(4):341-4. PubMed ID: 19097685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Narcolepsy: selective hypocretin (orexin) neuronal loss and multiple signaling deficiencies.
    Bassetti CL
    Neurology; 2005 Oct; 65(8):1152-3. PubMed ID: 16247037
    [No Abstract]   [Full Text] [Related]  

  • 9. Hypocretin (orexin) and melanin concentrating hormone loss and the symptoms of Parkinson's disease.
    Thannickal TC; Lai YY; Siegel JM
    Brain; 2008 Jan; 131(Pt 1):e87. PubMed ID: 17898004
    [No Abstract]   [Full Text] [Related]  

  • 10. Hypocretin/orexin disturbances in neurological disorders.
    Fronczek R; Baumann CR; Lammers GJ; Bassetti CL; Overeem S
    Sleep Med Rev; 2009 Feb; 13(1):9-22. PubMed ID: 18819824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sleep disorders in Parkinson's disease.
    Stocchi F; Vacca L; Valente M; Ruggieri S
    Adv Neurol; 2001; 86():289-93. PubMed ID: 11553988
    [No Abstract]   [Full Text] [Related]  

  • 12. Sleep and Parkinson's disease.
    Freedom T
    Dis Mon; 2007 May; 53(5):275-90. PubMed ID: 17656189
    [No Abstract]   [Full Text] [Related]  

  • 13. Sleep and Parkinson's disease.
    Rolan T
    Mo Med; 2006; 103(5):529-32. PubMed ID: 17133758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sleep disorders in Parkinson's disease and other movement disorders].
    Clavero P; Rodríguez-Oroz MC
    An Sist Sanit Navar; 2007; 30 Suppl 1():143-53. PubMed ID: 17486155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alertness and feeding behaviors in ADHD: does the hypocretin/orexin system play a role?
    Cortese S; Konofal E; Lecendreux M
    Med Hypotheses; 2008 Nov; 71(5):770-5. PubMed ID: 18678446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Regulatory mechanism of sleep/wakefulness states by orexin].
    Sakurai T
    Tanpakushitsu Kakusan Koso; 2007 Nov; 52(14):1840-8. PubMed ID: 18018635
    [No Abstract]   [Full Text] [Related]  

  • 17. Sleep disorders in Chinese patients with Parkinson's disease: validation study of a Chinese version of Parkinson's disease sleep scale.
    Wang G; Cheng Q; Zeng J; Bai L; Liu GD; Zhang Y; Tan YY; Pan J; Hong Z; Wang Y; Chen SD
    J Neurol Sci; 2008 Aug; 271(1-2):153-7. PubMed ID: 18508085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal fluid hypocretin-1 levels in multiple system atrophy.
    Martinez-Rodriguez JE; Seppi K; Cardozo A; Iranzo A; Stampfer-Kountchev M; Wenning G; Tolosa E; Högl B; Santamaria J; Poewe W;
    Mov Disord; 2007 Sep; 22(12):1822-4. PubMed ID: 17659646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Good practice in the assessment and management of nocturnal Parkinson's disease symptoms.
    Medcalf P
    Age Ageing; 2005 Sep; 34(5):435-8. PubMed ID: 16107451
    [No Abstract]   [Full Text] [Related]  

  • 20. Low levels of ventricular CSF orexin/hypocretin in advanced PD.
    Drouot X; Moutereau S; Nguyen JP; Lefaucheur JP; Créange A; Remy P; Goldenberg F; d'Ortho MP
    Neurology; 2003 Aug; 61(4):540-3. PubMed ID: 12939433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.